SABCS 2022 Highlights – HER2-low, PARP inhibitors, and more

Phase III trial updates and a HER2-low debate

Read time: 20 mins

Last updated: 8th Feb 2023

Published: 14th Dec 2022

Author: Heather Mason and Ben Gallarda

GEO restriction image This resource is only available for healthcare professionals outside of your region. Click below to browse other relevant learning materials.

Oncology resources

Complete the form below to receive our regular round-up of the latest clinical news and medical education resources on Medthority, straight to your inbox.

* = required information

Name

Email address

Specialty

By providing your email address, you are opting in to receive our monthly newsletter.

I agree to receive additional communications from Medthority related to my specialty.

We will never share your data, and you can withdraw consent at any time. Read our privacy policy here.